...
首页> 外文期刊>International Journal of Pharmaceutics >In vitro and in vivo methotrexate disposition in alveolar macrophages: comparison of pharmacokinetic parameters of two formulations.
【24h】

In vitro and in vivo methotrexate disposition in alveolar macrophages: comparison of pharmacokinetic parameters of two formulations.

机译:肺泡巨噬细胞中的甲氨蝶呤的体外和体内配置:两种制剂的药代动力学参数比较。

获取原文
获取原文并翻译 | 示例
           

摘要

MTX-liposomes, prepared with a polymerised core (LSP), were administered in anaesthetised rats by pulmonary instillation versus free drug. No toxicological effects were macroscopically observed. After each time point: 15, 30, 60 and 90 min, animals were humanely killed and analyses of radio-signal were done. This approach allowed recovery of MTX or breakdown products within biological samples. Previously, kinetics of MTX cellular uptake was performed to identify the cytotoxic concentration of drug formulation for human macrophage. Flow cytometry was set-up to characterise liposomal uptake by ex vivo pulmonary macrophage. Cells were isolated by bronchioloalveolar washes from animals. Results have shown clear different pharmacokinetic parameters between free MTX and the liposomal form of MTX. Unlike classical liposomes, which are mainly taken up by the reticulo-endothelial system, LSP-MTX was not targeted to spleen or kidney. The route of administration could be an explanation of this phenomenon. In addition, LSP-MTX was more retained by the lung tissue. Moreover, free form of the drug reaches easily lymph node. This latest result should be taken into consideration for neoplasic disease and more specifically when lymph nodes are a way for pulmonary metastasis. Finally, LSP-MTX should be tested in physio-pathological model of lung cancer to evaluate the influence of the variation of liposomal formulation pharmacokinetic parameters on the drug efficacy.
机译:用聚合核心(LSP)制备的MTX脂质体通过与游离药物相比的肺部滴注给药于麻醉的大鼠。宏观上没有观察到毒理作用。在每个时间点之后:15分钟,30分钟,60分钟和90分钟,将人道处死动物并进行放射信号分析。这种方法可以回收生物样品中的MTX或分解产物。以前,进行MTX细胞摄取的动力学以鉴定人巨噬细胞的药物制剂的细胞毒性浓度。建立流式细胞术以表征离体肺巨噬细胞摄取脂质体。通过从动物支气管肺泡洗涤分离细胞。结果表明,游离MTX和MTX脂质体形式之间存在明显不同的药代动力学参数。与主要由网状内皮系统摄取的经典脂质体不同,LSP-MTX并非针对脾脏或肾脏。管理途径可以解释这种现象。另外,LSP-MTX被肺组织更多地保留。此外,药物的游离形式很容易到达淋巴结。对于赘生性疾病,尤其是在淋巴结转移是肺转移的一种方法时,应考虑这一最新结果。最后,应在肺癌的生理病理模型中测试LSP-MTX,以评估脂质体制剂药代动力学参数的变化对药物疗效的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号